General review
On the regulation of sex-hormone-binding globulin—A challenge of an old dogma and outlines of an alternative mechanism

https://doi.org/10.1016/0022-4731(89)90272-0Get rights and content

Abstract

In this review, the different factors known to affect SHBG levels are discussed with respect to their possible significance in the physiological regulation of this protein: Sex steroids, puberty, nutritional status, thyroid hormones and liver disease. It is concluded that the serum levels of SHBG are related rather to general metabolic factors, nutritional status, growth and ageing than to the estrogen/androgen balance. The authors suggest that SHBG is regulated primarily by growth hormone, somatomedin-C and possibly other growth factors. Growth hormone may promote SHBG synthesis in the liver while somatomedin-C may stimulate its extravasation and uptake in target tissues. It is suggested that sex steroids merely have an indirect, modulating influence.

References (102)

  • N. Fröhlander et al.

    Growth hormone and somatomedin C during postmenopausal replacement with oestrogen alone and in combination with an antioestrogen

    Maturitas

    (1988)
  • E.E. Griffin et al.

    Effects of hypophysectomy on rat liver donors on net synthesis of specific plasma proteins by the isolated perfused rat liver

    J. biol. Chem.

    (1974)
  • P. De Moor et al.

    Growth hormone and the steroid binding β-globulin of human plasma

    J. steroid Biochem.

    (1972)
  • S.A. Duursma et al.

    Oestrogens and bone metabolism: a hypothesis

    Maturitas

    (1986)
  • K. Hall et al.

    Somatomedin levels in childhood, adolescence and adult life

    Clin. endocr. Metab.

    (1984)
  • D.C. Anderson

    Sex-hormone-binding globulin

    Clin. Endocr.

    (1974)
  • A. Belgorosky et al.

    Sex hormone binding globulin in arterial and in peripheral, hepatic, renal and spermatic venous blood of children and adults

    Acta endocr. Copenh.

    (1983)
  • W. Rosner et al.

    Hormonal influences on the secretion of steroid-binding proteins by a human hepatoma-derived cell line

    J. clin. Endocr. Metab.

    (1984)
  • P.H. Petra et al.

    Characterization of the plasma sex steroidbinding protein

  • J.F. Dunn et al.

    Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma

    J. clin. Endocr. Metab.

    (1981)
  • R.P. Ekins et al.

    The role of binding proteins in hormone delivery

  • B. Nilsson et al.

    Serum levels of unbound 17β-oestradiol during oral and percutaneous replacement therapy

    Br. J. Obstet. Gynaec.

    (1984)
  • R.A. Vigersky et al.

    Relative binding of testosteroneestradiol binding globulin

    J. clin. Endocr. Metab.

    (1979)
  • M.N. El Makhzangy et al.

    Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids

    Clin. Endocr.

    (1979)
  • S. Helgason et al.

    A comparative longitudinal study on sex hormone binding globulin capacity during estrogen replacement therapy

    Acta Obstet. Gynec. Scand.

    (1982)
  • J.R. Pogmore et al.

    Sex hormone binding globulin capacity and postmenopausal hormone replacement therapy

    Br. J. Obstet. Gynaecol.

    (1979)
  • G.D. Carter et al.

    Investigation of hirsutism: testosterone is not enough

    Ann. clin. Biochem.

    (1983)
  • S.K. Cunningham et al.

    Plasma sex hormone binding globulin and androgen levels in the management of hirsute patients

    Acta endocr. Copenh.

    (1983)
  • L. Daehlin et al.

    The oestrogenic effects of ethinyloestradiol/polyoestradiol phosphate and estramustine phosphate in patients with prostatic carcinoma

    Br. J. Urol.

    (1986)
  • C.B. Laurell et al.

    Comparison of plasma protein changes induced by danazol, pregnancy and estrogens

    J. clin. Endocr. Metab.

    (1979)
  • J. Holst et al.

    A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy

    Br. J. Obstet. Gynaec.

    (1983)
  • J.M. Kuhn et al.

    Effects of 10 days administration of percutaneous dihydrotestosterone on the pituitary-testicular axis in normal men

    J. clin. Endocr. Metab.

    (1984)
  • P. Leinonen et al.

    Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration and their combination in men with prostatic carcinoma

    Invest. Urol.

    (1979)
  • S.R. Plymate et al.

    Sex hormone-binding globulin changes with androgen replacement

    J. clin. Endocr. Metab.

    (1983)
  • V. Odlind et al.

    Effects of oestradiol on sex hormone binding globulin

    Acta endocr. Copenh.

    (1982)
  • K.A. Steingold et al.

    Enhanced hepatic extraction of estrogens used for replacement therapy

    J. clin. Endocr. Metab.

    (1986)
  • R. Stege et al.

    Steroid-sensitive proteins, growth hormone and somatomedin C in prostatic cancer: effects of parenteral and oral estrogen therapy

    The Prostate

    (1987)
  • M. Dowsett et al.

    Oestrogen-related changes in sex hormone binding globulin levels during normal and gonadotrophinstimulated menstrual cycles

    Clin. Endocr.

    (1985)
  • D. Aptér et al.

    Serum sex hormone-binding globulin during puberty in girls and in different types of adolescent menstrual cycles

    Acta endocr., Copenh.

    (1984)
  • S.R. Plymate et al.

    Sex hormone-binding globulin changes during the menstrual cycle

    J. clin. Endocr. Metab.

    (1985)
  • L. Skjöldebrand-Sparre et al.

    Oestrogen and thyroxine-binding globulin levels in early normal pregnancy

    Acta endocr., Copenh.

    (1987)
  • L. Skjöldebrand et al.

    Serum levels of oestrogens and of five “steroid sensitive” proteins in early normal pregnancy

    Acta endocr., Copenh.

    (1988)
  • Y. Maruyama et al.

    Variation with age in the levels of sex-steroid-binding plasma protein as determined by radioimmunoassay

    Acta endocr. Copenh.

    (1984)
  • K. Carlström et al.

    Influence of orchidectomy or oestrogen treatment on serum levels of pregnancy associated α2-glycoprotein and sex hormone binding globulin in patients with prostatic cancer

    Int. J. Androl.

    (1985)
  • J.-E. Damber et al.

    Binding capacity of testosterone-estradiol-binding globulin (TeBG), total and calculated unbound concentrations of testosterone in patients with carcinoma of the prostate treated with orchidectomy or estrogens

    J. Endocr. Invest.

    (1983)
  • A. Belgorosky et al.

    Progressive decrease in serum sex hormone-binding globulin from infancy to late prepuberty in boys

    J. clin. Endocr. Metab.

    (1986)
  • S.H. Cunningham et al.

    Plasma sex hormone-binding globulin levels decrease during the second decade of life irrespective of pubertal status

    J. clin. Endocr. Metab.

    (1984)
  • D.J. Evans et al.

    Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women

    J. clin. Endocr. Metab.

    (1983)
  • P.G. Kopelman et al.

    The effect of weight loss on sex steroid secretion and binding in massively obese women

    Clin. Endocr. Oxf.

    (1981)
  • R. Tegelman et al.

    Peripheral hormone levels in healthy subjects during controlled fasting

    Acta endocr, Copenh.

    (1986)

    • Cited by (181)

    • The Effect of Obesity on Reproductive Health

      2017, Practical Guide to Obesity Medicine

    • Cut-off levels for hyperandrogenemia among Samoan women: An improved methodology for deriving normative data in an obese population

      2016, Clinical Biochemistry
      Citation Excerpt :

      Non-diabetic women with HA furthermore had higher median insulin levels and HOMA-IR compared to non-diabetic women with normal androgen levels. These findings are consistent with the key role that body fat plays in altering the secretion, transportation, metabolism, and the action of androgens, while androgens can in turn contribute to increased susceptibility to type 2 diabetes and cardiovascular disease [4,5,23,24,25]. Given the rise in average BMI and prevalence of obesity globally, other studies can use a similar approach in defining biochemical HA among their study samples.

    • Androgen Physiology, Pharmacology, and Abuse

      2015, Endocrinology: Adult and Pediatric

    • Obesity, Polycystic Ovaries and Impaired Reproductive Outcome

      2013, Obesity

    • Biological significance of a thyroid hormone-regulated secretome

      2013, Biochimica et Biophysica Acta - Proteins and Proteomics
      Citation Excerpt :

      Payne et al. [181] suggested that the concentration of cell-secreted SHBG is enhanced by TH and reduced by insulin in a dose-dependent manner. SHBG is a glycoprotein whose synthesis and secretion are regulated by the liver [182,183]. Additionally, SHBG plays a critical role in modulating steroid-induced cell growth via interactions with its receptor [184] (Fig. 3A, g).

    • Obesity, Polycystic Ovaries and Impaired Reproductive Outcome

      2012, Obesity: A Ticking Time Bomb for Reproductive Health
    View all citing articles on Scopus
    View full text
    Copyright © 1989 Published by Elsevier Ltd.